Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2

Chen-Wen Chen1, Qian-Bo Chen, Qing Ouyang

  • 1Department of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China. 1002153376@qq.com.

Insights

Activated microglia

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia's dual role in neuronal health and damage is incompletely understood.
  • Signaling pathways governing microglial beneficial vs. detrimental actions require elucidation.

Purpose of the Study:

  • To investigate the temporal signaling mechanisms of microglial activation by Protease-Activated Receptor 2 (PAR-2).
  • To determine the impact of PAR-2 stimulation timing on neuronal outcomes.
  • To explore the modulatory roles of Protease-Activated Receptor 1 (PAR-1) in microglial responses.

Main Methods:

  • Primary microglial cultures were stimulated with a PAR-2 agonist (2-Furoyl-LIGRLO-NH2).
  • Microglial conditioned medium (MCM) from early (1h) and late (72h) phases was applied to cultured neurons.
  • PAR-1 blockade and agonism were employed during different phases of PAR-2 stimulation.
  • Neuronal apoptosis was assessed using TUNEL and annexin/PI staining.

Main Results:

  • Early PAR-2 stimulation transiently released Brain-Derived Neurotrophic Factor (BDNF).
  • Sustained PAR-2 stimulation led to delayed release of inflammatory cytokines (IL-1β, TNF-α) and nitric oxide (NO).
  • Early-phase MCM was neuroprotective, while late-phase MCM induced neuronal apoptosis.
  • PAR-1 blockade enhanced BDNF release; PAR-1 agonism suppressed late-phase cytokine/NO release.

Conclusions:

  • Neuroprotective and neurotoxic microglial effects have distinct temporal profiles.
  • PAR-1 and PAR-2 signaling critically regulate these temporal responses.
  • Targeted modulation of microglial PAR-1 and PAR-2 offers potential for promoting neuronal repair.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...